Our internationally recognised publications give you access to the expertise of hundreds of the world’s leading scientists, experts and researchers.

Our unrivalled collection of publications spans evidence-based clinical knowledge, research and regulatory information. The extensive breadth of content on MedicinesComplete supports your decision making, from research to the point of care and provides you with the world’s most trusted resources.

We’re excited to announce the launch of two new resources: Martindale’s ADR Checker, a quick and easy tool to support you when managing patients with adverse drug reactions, and the Palliative Care Formulary, the expert source of drug information in palliative and hospice care.

Subscribe Publication Updates

Publication Updates

12 Feb
Dietary Supplements logo
Dietary Supplements February 2019 Update

This update contains revisions to Aloe Vera, Beta Glucan, Magnesium, Potassium, Psyllium and Vitamin E monographs.

12 Feb
Palliative Care Formulary February 2019 Update 

This update contains 6 revised monographs.

Revised monographs: Zinc; Loperamide; Mirtazapine; Olanzapine; Catheter patency; Antidepressants.

12 Feb
AHFS Drug Information logo
AHFS Drug Information February 2019 update 

This update contains 5 new monographs, 8 revised monographs and 2 discontinued monographs.

New monographs: Cenegermin-bkbj; Emapalumab-lzsg; Larotrectinib; Glasdegib; Gilteritinib

Revised monographs: Pitavastatin; Azilsartan; Mepolizumab; Lutetium Lu 177 Dotatate; Megestrol; chlordiazePOXIDE; Fosfomycin; tiaGABine Hydrochloride

Discontinued monographs: Dasabuvir, Ombitasvir, Paritaprevir, and Ritonavir; Ombitasvir, Paritaprevir, and Ritonavir

12 Feb
Stockleys Drug Interactions_logo
Stockley’s Drug Interactions February 2018 update

Stockley’s Drug Interactions update with new and revised monographs.

For this update, new classification tables of inhibitors and substrates of the drug transporter proteins BCRP, MATE, OAT, OATP, and OCT, based on clinical pharmacokinetic data have been added, along with a new table of drugs that lower the seizure threshold. Several sections have been completely re-validated and updated, including those on HCV drugs and the HIV-protease inhibitors.  This update contains 39 new monographs, and 692 existing monographs have been updated.

12 Feb
Stockley's Interactions Checker_logo
Stockley’s Interaction Checker February 2019 update 

New and updated interactions now available 

For January, 699 new interactions have been added, and 1559 existing interactions have been updated

12 Feb
British National Formulary for Children logo
BNFC February 2019 update

This update contains 6 significant change  and 1 new preparation. 

Significant Changes:  

  • Direct-acting antivirals for chronic hepatitis C (sofosbuvir): risk of hypoglycaemia in patients with diabetes [MHRA/CHM advice].
  • Emollients (see Emollient and barrier preparations): new information about risk of severe and fatal burns with paraffin-containing and paraffin-free emollients [MHRA/CHM advice].
  • Gemtuzumab ozogamicin for untreated acute myeloid leukaemia [NICE guidance].
  • Hydrocortisone muco-adhesive buccal tablets: should not be used off-label for adrenal insufficiency in children due to serious risks [MHRA/CHM advice].
  • Smoking cessation: updated guidance.
  • Valproate medicines (see sodium valproate and valproic acid): are you acting in compliance with the pregnancy prevention measures? [MHRA/CHM advice].

New Preparations: Nplate® [romiplostim]

For further details on changes in the BNFC click on https://www.medicinescomplete.com/#/content/bnfc/PHP107699?hspl=changes 

View more